I am expecting additional information to be incremental trial data... the trials take time and until final data/results are available I can get excited about the continuing length of good indicative data. They might also provide some fluffy statements about a positive tracking and outlook but I doubt there will be much substance i.e. nothing that new that can be used to make conclusive investment decisions.
Don't get me wrong - I'm positive, but cautious that advancement in medical science can hit hurdles at various stages during testing.
Friday thoughts IMU, page-94
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(1.04%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.9¢ | 4.8¢ | $470.4K | 9.799M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 1458432 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2349191 | 20 |
View Market Depth
| Last trade - 12.17pm 10/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |